AzTrials
AzTrials

Extracorporeal Shock WaveNCT06762197

Radial Shockwave Versus Low Level Laser Therapy in Patients With Chronic Piriformis Muscle Syndrome

A study testing Conventional treatment, shockwave therapy and low level laser therapy in people with Extracorporeal Shock Wave and Radial Shock Wave, run by Cairo University at 1 site in Egypt.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

The study aims to compare the effects of radiation shockwave and low-level laser therapy on piriformis muscle thickness, lower extremity function, pain intensity, and hip range of motion in patients with piriformis syndrome. Read more about this study

Who is it for?
Ages 30 to 50 years
What is being tested?
Conventional treatment, shockwave therapy and low level laser therapy
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
63 participants
Where
1 siteEgypt
Study dates
1 Jan 2025to 1 Apr 2025
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 30 to 50 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • Sixty patients' males and females with piriformis syndrome
  • Their age will range from 30-50 years old
  • Body mass index will be 25 to 30 (kg/m²).
  • Both males and females.
  • Low back pain radiating to posterior thigh, calf and Foot.
  • Chronic piriformis syndrome due to micro trauma.
Show all 11Show fewer
  • Gluteal pain with or without radiation through sciatic nerve pathway.
  • Faber test and Fair test and Beatty test positive.
  • Diagnosed sub-acute and chronic piriformis syndrome.
  • One-sided piriformis syndrome.
  • Tenderness over lower back, buttocks and hip joint.

Who cannot join

  • Piriformis syndrome due to macro trauma.
  • Lumbo-sacral disc lesion and spinal stenosis.
  • Lumbar spondylolisthesis.
  • Pregnancy
  • Recent fracture and surgery of spine, hip, knee and Ankle.
  • Baker's cyst.
Show all 13Show fewer
  • Degenerative disease of spine and hip.
  • Intermittent vascular claudication.
  • Past history of vertebral fracture and spinal surgery
  • Spinal tuberculosis.
  • Rheumatoid disease.
  • Disc pathology and mechanical back pain.
  • Presence of malignant disease.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Mohamed Mahdy Ali, physical therapist contact

01111153111

M_mahdy142@yaho.com

Egypt1 site
  • out-patient clinic in physiotherapy department at EL KATEB Hospital

    Giza

    Mohamed Mahdy Ali, physical therapist, 01111153111, m_mahdy142@yahoo.com

Other trials in Egypt

About this study

Official title: Radial Extracorporeal Shockwave Versus Low Level Laser Therapy in Management of Patients With Chronic Piriformis Muscle Syndrome

The study aims to compare the effects of radiation shockwave and low-level laser therapy on piriformis muscle thickness, lower extremity function, pain intensity, and hip range of motion in patients with piriformis syndrome.

Read the detailed description

Low back pain affects 75%-84% of the general population in developed countries, with piriformis syndrome being more common in women. piriformis syndrome is a neuromuscular disorder caused by the compression of the sciatic nerve in the infra-piriformis canal, causing sciatic pain, tingling, and numbness. Few studies have examined the effectiveness of shockwave therapy in treating piriformis syndrome, but this study aims to compare results to improve treatment outcomes, save time and money, and add value to physical therapy.

Being tested
Conventional treatment, shockwave therapy, low level laser therapy
Medical subject headings
Piriformis Muscle Syndrome

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Conventional treatmentOther

    Physical therapy can be beneficial for patients with piriformis syndrome, including stretching exercises, local massage, and superficial heat. Traditional stretching techniques include external rotation, hip flexion, and adduction. A hot pack on the trigger point area for 10 minutes followed by passive stretching for 30 seconds each.

  • shockwave therapyDevice

    Shockwave therapy is a non-invasive alternative treatment for muscle disorders like sports and traumatic injuries, as it reduces pain and promotes soft tissue repair. In a study, patients in group A were treated with three sessions of Storz Medical Shock Wave MP100, each consisting of 2000 pulses with a total energy dose of 1080 mJ / mm. The study aimed to determine the location of the piriformis muscle in the prone position.

  • low level laser therapyDevice

    Low Level Laser Therapy, also known as Photo-biomodulation, is a low-intensity light therapy that triggers biochemical changes within cells, similar to photosynthesis in plants. It can treat nociceptive and neuropathic pain, but central pain has not been proven responsive to low level laser therapy.

Study groups in NCT06762197
Study groupRoleWhat they receive
conventional programActive comparatortwenty one patients of chronic piriformis muscle syndrome will be treated by the conventional physical therapy program in the form of (hot packs, local massage and stretching exercise) for 6 weeks (two times per week).
Receives: Other: Conventional treatment
Radial Extracorporeal shock waveExperimentaltwenty one patients of chronic piriformis muscle syndrome will be treated with Radial Extracorporeal shock wave in addition to the conventional physical therapy program in the form of (hot packs, local massage and stretching exercise) for 6 weeks (two times per week).
Receives: Other: Conventional treatment; Device: shockwave therapy
low level laser therapyExperimentaltwenty one patients of chronic piriformis muscle syndrome will be treated with low level laser therapy in addition to the conventional physical therapy program in the form of (hot packs, local massage and stretching exercise) for 6 weeks (two times per week).
Receives: Other: Conventional treatment; Device: low level laser therapy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Assessing the change of body mass index

    Weight and height Scale will be used to measure body mass index

    Measured: at baseline and after 6 weeks

  2. assessing the change of pain intensity

    The 10-cm visual analogue scale has been proven reliable, valid, and responsive for assessing pain levels, with 0 indicating no pain and 10 indicating the worst pain possible, demonstrating its effectiveness in measuring pain.

    Measured: at baseline and after 6 weeks

Secondary outcomes (3)
  1. assessing the change of functional status

    The patient's functional status is assessed using the Lower Extremity Functional Scale before treatment. This self-assessment tool is valid and reliable, and the patient's score on the questionnaire is evaluated. The scale is free for clinical or research purposes.

    Measured: at baseline and after 6 weeks

  2. assessing the change of range of motion of lower limb

    Goniometer measurement is used to assess the range of motion of hip internal and external rotation before and after intervention. This simple test is accurate and reliable in detecting changes in hip range of motion, making it a valid measure to detect underlying hip pathology and enable surgical intervention based on it.

    Measured: at baseline and after 6 weeks

  3. assessing the change of piriformis muscle thickness

    Ultrasound guided measurement for piriformis M.sc thickness may be a reliable technique for early diagnosis of post-operative pain syndrome, increasing conservative treatment options and routinely evaluating patients with unidentified causes of buttock pain. The technique involves placing a probe in the patient's prone position, moving the patient's lower leg to confirm the piriformis position, and measuring piriformis thickness in the medial part of the ischium.

    Measured: at baseline and after 6 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted7 Jan 2025
  2. Study start1 Jan 2025 (estimated)
  3. Primary completion1 Mar 2025 (estimated)
  4. Study completion1 Apr 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
63 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06762197
Sponsor's protocol ID
Mohamed-004968
Status last verified
Jan 2025
First submitted
1 Jan 2025
Last updated
7 Jan 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Conventional treatment, shockwave therapy and low level laser therapy in people with Extracorporeal Shock Wave and Radial Shock Wave, run by Cairo University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 11 inclusion and 13 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 7 Jan 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Mohamed Mahdy Ali, physical therapist (01111153111, M_mahdy142@yaho.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Assessing the change of body mass index (time frame: at baseline and after 6 weeks). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Jan 2025.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in